Drug-induced liver disease

Current Opinion in Gastroenterology

Volumn 16, Issue 3, 2000, Pages 231-238

  Mayoral, William ^a   Lewis, James H ^a  

^a GEORGETOWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; AMIODARONE; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; ASPARTATE AMINOTRANSFERASE; BROMFENAC; CHLORPROMAZINE; CLAVULANIC ACID; DEXTROPROPOXYPHENE; DICLOFENAC; FLUOXETINE; GAMMA GLUTAMYLTRANSFERASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; METHYLDOPA; MEVALONIC ACID; NEFAZODONE; NITROFURANTOIN; NONSTEROID ANTIINFLAMMATORY AGENT; PHENYTOIN; PLANT EXTRACT; PRAVASTATIN; PSYCHOTROPIC AGENT; ROSIGLITAZONE; SIMVASTATIN; TETRACYCLINE; TROGLITAZONE; TROVAFLOXACIN; UNINDEXED DRUG; URSODEOXYCHOLIC ACID;

AMINOTRANSFERASE BLOOD LEVEL; CLINICAL TRIAL; DRUG INDUCED DISEASE; HEPATITIS; HUMAN; JAUNDICE; LIVER BIOPSY; LIVER FAILURE; LIVER INJURY; LIVER PROTECTION; META ANALYSIS; NONHUMAN; REVIEW;

EID: 0034465754     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001574-200005000-00005     Document Type: Review

References (50)

1. Hepatotoxicity: The adverse effects of drugs and other chemicals on the liver
2. The natural history of histologically proved drug-induced liver disease
3. Drug- and chemical-induced choriostasis
4. Transaminase elevations on placebo during phase I trials: Prevalence and significance
5. The prevalence incidence of medical conditions in healthy pharmaceutical company employees who volunteer to participate in medical research
6. Nefazodone-induced liver failure: Report of three cases
7. Acute cholestatic hepatitis associated with pravastatin
8. Atorvastatin-induced cholestatic jaundice in a young woman with systemic lupus erythematosus
9. Toxicity of the HMG-coenzyme A reductase inhibitor, lovastatin, to rabbits
10. Preclinical safety. Evaluation of cervistatin, a novel HMG-CoA reductase inhibitor
11. Drug-induced liver disease
12. Troglitazone: A review of its use in the management of type 2 diabetes mellitus
13. Clinical pharmacokinetics and pharmacodynamics of bromfenac
14. Bromfenac (Duract)-associated hepatic failure requiring liver transplantation
15. Severe hepatotoxicity associated with bromfenac sodium
16. NSAID-induced hepatotoxicity
17. Hepatic metabolism of diclofenac: Role of human CYP in the minor oxidative pathways
18. Hepatotoxicity possibly caused by amphotericin B
19. Omeprazole and the development of acute hepatitis
20. Hepatotoxicity related to intracavernous pharmacotherapy with papaverine
21. Hepatocellular ademonas in patients taking Danazol for hereditary angioedema
22. Mesalamine induced granulomatous hepatitis
23. Quinine-induced hepatotoxicity
24. Acute pseudo-hepatitis in a chronic substance abuser secondary to occult seat-belt injury
25. Frequency of flutamide-induced hepatotoxicity in patients with prostate carcinoma
26. Flutamide-induced acute hepatitis: Investigation on the role of immunoallergic mechanisms
27. Fulminant liver failure associated with flutamide therapy for hirsutism
28. Anti-androgen hepatotoxicity in patients with chronic viral hepatitis
29. Fatal fulminant hepatic failure due to cyproterone acetate
30. Liver function in postmenopausal women on estrogen-androgen hormone replacement therapy: A meta-analysis of eight clinical trials
31. Anabolic steroid-induced hepatotoxicity: Is it overrated?
32. Antiepileptic drug hypersensitivity syndrome
33. Suspected carbamazepine-induced hepatotoxicity
34. Acute liver failure caused by Isoniazid in a patient receiving carbamazapine
35. Felbamate in epilepsy therapy: Evaluating the risks
36. Acute hepatitis due to fluoxetine therapy
37. Risperidone-induced hepatotoxicity in children and adolescents? A chart review study
38. Fatal liver failure associated with valproate therapy in a patient with Friedreich's disease: Review of valproate hepatotoxicity in adults
39. Isoflurane hepatotoxicity in a patient with a previous history of halothane-induced hepatitis
40. Hepatotoxicity following desflurane anesthesia
41. Protection against acetaminophen toxicity in CYP1A2 and CYP2E1 double-null mice
42. Alcohol-mediated increases in acetaminophen hepatotoxicity: Role of CYP2E and CYPeA
43. Hypothyroidism protects rat liver from acetaminophen hepatotoxicity
44. Antihepatotoxic activity of Swertia chirata on paracetamol and galactosamine induced hepatotoxicity in rats
45. Deferoxamine delays the development of the hepatotoxicity of acetaminophen in mice
46. Evaluation of hepatoprotective activity of Cassia fistula leaf extract
47. Treatment with aged garlic extract protects against bromobenzene toxicity to precision cut rat liver slices
48. The effect of pretreatment with glycyrrhizin and glycyrrhetinic acid on the retrosine-induced hepatotoxicity in rats
49. Free radical scavenging action of medicinal herbs from Ghana: Thonningia sanguinea on experimentally-induced liver injuries